ArticleOpen forum infectious diseases2017

Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials.

Thomas P Lodise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.